中国寄生虫学与寄生虫病杂志 ›› 2022, Vol. 40 ›› Issue (6): 798-800.doi: 10.12140/j.issn.1000-7423.2022.06.017

• 标准解读 • 上一篇    下一篇

《日本血吸虫抗体检测标准 酶联免疫吸附试验法》解读

严晓岚1(), 闻礼永1(), 熊彦红2, 郑彬2, 张剑锋1, 汪天平3, 俞丽玲1, 许国章4, 林丹丹5, 周晓农2   

  1. 1.杭州医学院,浙江省血吸虫病防治中心,杭州 310013
    2.中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心),国家卫生健康委员会寄生虫病原与媒介生物学重点实验室,世界卫生组织热带病合作中心,国家级热带病国际联合中心,上海 200025
    3.安徽省寄生虫病防治研究所,合肥 230061
    4.宁波市疾病预防控制中心,宁波 315010
    5.江西省寄生虫病防治研究所,南昌 330000
  • 收稿日期:2022-04-25 修回日期:2022-08-08 出版日期:2022-12-30 发布日期:2022-12-09
  • 通讯作者: 闻礼永
  • 作者简介:严晓岚(1970-),女,本科,正高级实验师,从事血吸虫病防治。E-mail:yxlhz2005@126.com
  • 基金资助:
    国家卫生和计划生育委员会政策法规司项目(20180301);国家社会科学基金重大项目(16ZDA237)

Interpretation of Criteria for Detection of Antibody against Schistosoma japonicumEnzyme-linked Immunosorbent Assay

YAN Xiao-lan1(), WEN Li-yong1(), XIONG Yan-hong2, ZHENG Bin2, ZHANG Jian-feng1, WANG Tian-ping3, YU Li-ling1, XU Guo-zhang4, LIN Dan-dan5, ZHOU Xiao-nong2   

  1. 1. Hangzhou Medical College, Zhejiang Provincial Center for Schistosomiasis Control,Hangzhou 310013, China
    2. National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research); NHC Key Laboratory of Parasite and Vector Biology; WHO Collaborating Centre for Tropical Diseases; National Center for International Research on Tropical Diseases,Shanghai 200025, China
    3. Anhui Institute of Parasitic Diseases, Hefei 230061, China
    4. Ningbo Municipal Center for Disease Control and Prevention, Ningbo 315010, China
    5. Jiangxi Provincial Institute of Parasitic Diseases, Nanchang 330000, China
  • Received:2022-04-25 Revised:2022-08-08 Online:2022-12-30 Published:2022-12-09
  • Contact: WEN Li-yong
  • Supported by:
    National Health and Family Planning Commission of China(20180301);Major Projects of National of Social Science Foundation of China(16ZDA237)

摘要:

遵循《卫生标准管理办法》相关规定,按照《标准化工作导则 第1部分:标准化文件的结构和起草规则》(GB/T 1.1—2020)体例,编制《日本血吸虫抗体检测标准 酶联免疫吸附试验法》。标准全文由六章组成,包括范围、规范性引用文件、术语和定义、仪器设备、试剂或材料、检测步骤。另附有2个资料性附录(主要试剂材料制备方法,检测步骤示意图和注意事项)。该标准已由国家卫生健康委员会发布通告(国卫通〔2021〕11号),定于2022年5月1日起实施。该标准的实施将进一步推进我国血吸虫病检测技术规范化进程,为全国实现消除血吸虫病目标提供重要的技术支撑。

关键词: 日本血吸虫, 酶联免疫吸附试验, 标准

Abstract:

The criteria compilation for the detection of antibodies against Schistosoma japonicum using enzyme linked immunosorbent assay was performed based on the documents of Management Measures for Health Criteria and Directives for standardization-Part 1. Rules for the structure and drafting of standardizing documents (GBT 1.1—2020). The criteria are composed of six chapters which include the range of applications, normative reference documents, terms and definitions, instruments and equipment, reagent or materials and detection steps. Two informative appendices (including preparation method of main reagent materials, and schematic diagram of detection steps and points for attention) is appended along with the criteria. The criteria was issued by the National Health Commission of the People’s Republic of China through No.11 of Chinese Health Announcement and had implemented since May 1, 2022. The criteria will further promote the standardization process of schistosomiasis detection technology and provide important technical support for achieving the goal of schistosomiasis elimination in China.

Key words: Schistosoma japonicum, Enzyme-linked immunosorbent assay, Criteria

中图分类号: